Genes, muscles, and answers: how genetic counseling can help with neuromuscular diseases

Neuromuscular diseases (NMDs) encompass a wide range of disorders that can affect the muscles and the nerves controlling them. From Duchenne muscular dystrophy to spinal muscular atrophy (SMA), these diseases present significant challenges for patients and their families, especially in understanding the underlying causes, disease progression, and available treatment options. One crucial element of [...]

By , |2025-02-24T10:16:46+00:00February 28, 2025|News, Post blog|

AI and genetics are changing the future of muscular dystrophy diagnosis

Understanding muscular dystrophy through AI and genetics The power of precision medicine in neuromuscular disorders Muscular dystrophy is a complex group of genetic disorders that progressively weaken muscles, affecting mobility and quality of life. Traditional methods of diagnosing and categorizing these conditions rely on symptoms and genetic testing, but a new frontier is emerging. [...]

By , |2025-02-13T15:22:41+00:00January 30, 2025|News, Post blog|

Artificial Intelligence: Between Nobel Prizes and European Health Projects

What do the 2024 Nobel Prizes in Physics and Chemistry have in common with the CoMPaSS-NMD Project? Two words: Artificial Intelligence (AI). "For fundamental discoveries and inventions that have made machine learning possible with artificial neural networks". This is the official recognition given to the 2024 Nobel Prize in Physics, jointly awarded to John [...]

By |2024-11-18T13:05:07+00:00October 11, 2024|News, Post blog|
Go to Top